In brief Circle’s CRCL shares dropped 20% on Tuesday following a recent surge in value for the firm’s stock. Stablecoin giant Tether …
stock
-
-
Markets
Robinhood reloads stock repurchase plan to $1.5 billion as shares continue in downtrend
by shayaanby shayaanRiding the crypto boom to become one of the 2025’s hottest stocks, HOOD has shed more than 50% of its value since …
-
Markets
Bitcoin slips below $70,000, Circle's 16% slide leads crypto stock sell-off
by shayaanby shayaanMarket participants are now pricing in rate hikes, and it could be weighing on risk assets. www.coindesk.com
-
Markets
New York Stock Exchange taps Securitize to build its tokenized stock platform
by shayaanby shayaanThe move comes as the race to bring equities to always-on blockchain markets is heating up after Nasdaq obtained regulatory approval for …
-
Analysis
Strategy expands $60 billion stock issuance for Bitcoin strategy shake-up
by shayaanby shayaanStrategy (formerly MicroStrategy) widened its at-the-market fundraising capacity on March 23, filing new programs for common stock and two preferred securities, bringing …
-
Smart Contracts
Gemini Faces Class-Action Suit Over Prediction Market Pivot, Plummeting Stock Price
by shayaanby shayaanIn short Gemini is being sued by shareholders for allegedly misleading investors and concealing its pivot to prediction markets. Founders Tyler and …
-
Markets
Coinbase introduces stock perpetual futures contracts for non-U.S. customers
by shayaanby shayaanThe contracts trade 24/7, are cash-settled in USDC and allow for up to 10-times leverage on single-stock contracts and 20-times on ETF …
-
SoFi Technologies (NASDAQ: SOFI) is drawing attention after recording a notable insider purchase by the company’s top executive, signalling renewed confidence in …
-
Finance
Why this boring stablecoin stock is suddenly the hottest trade in crypto
by shayaanby shayaanShares of stablecoin issuer Circle (CRCL) have surged more than 100% over the past month, turning what many investors once viewed as …
-
Finance
Alto Neuroscience stock rises as firm secures $120M to advance depression drug
by shayaanby shayaanAlto Neuroscience, a clinical-stage biopharmaceutical company focused on neuropsychiatric disorders, has secured $120 million from institutional and accredited investors to advance ALTO-207, …